{"References": [{"title": "Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered T cells", "authors": "Choi, B.D., Yu, X., Castano, A.P., Darr, H., Henderson, D.B., Bouffard, A.A., Larson, R.C., Scarfo, I., Bouffard, A.A., Maus, M.V.", "journal": "Nature Biotechnology", "year": "2019", "volumes": "37", "first page": "1049", "last page": "1058", "DOI": "10.1038/s41587-019-0206-6"}, {"title": "Bispecific T-cell engagers: Preclinical and clinical development in hematologic malignancies", "authors": "Goebeler, M.E., Knop, S., Viardot, A., Kufer, P., Topp, M.S., Einsele, H., Baeuerle, P.A.", "journal": "Oncoimmunology", "year": "2018", "volumes": "7", "first page": "e1456116", "last page": "e1456116", "DOI": "10.1080/2162402X.2018.1456116"}, {"title": "Engineering T cells with chimeric antigen receptors to combat cancer", "authors": "June, C.H., O'Connor, R.S., Kawalekar, O.U., Ghassemi, S., Milone, M.C.", "journal": "Nature Reviews Immunology", "year": "2018", "volumes": "18", "first page": "459", "last page": "471", "DOI": "10.1038/s41577-018-0009-4"}, {"title": "Antigen escape and challenges to CAR T-cell therapy", "authors": "Majzner, R.G., Mackall, C.L.", "journal": "Nature Reviews Clinical Oncology", "year": "2019", "volumes": "16", "first page": "373", "last page": "385", "DOI": "10.1038/s41571-019-0184-z"}, {"title": "Dual targeting of acute myeloid leukemia with bispecific CD123-CD33 chimeric antigen receptor T cells", "authors": "Fry, T.J., Shah, N.N., Orentas, R.J., Stetler-Stevenson, M., Yuan, C.M., Ramakrishna, S., Wolters, P.L., Martin, S., Delbrook, C., Yates, B.", "journal": "Blood", "year": "2018", "volumes": "131", "first page": "746", "last page": "758", "DOI": "10.1182/blood-2017-07-793497"}, {"title": "Trispecific killer engagers: Next-generation, T cell-recruiting antibody constructs with high anti-tumor activity", "authors": "Slaga, D., Ellerman, D., Lombana, T.N., Vij, R., Li, J., Hristopoulos, M., Clark, R., Johnston, J., Shelton, A., Moore, G.L.", "journal": "Oncoimmunology", "year": "2018", "volumes": "7", "first page": "e1468957", "last page": "e1468957", "DOI": "10.1080/2162402X.2018.1468957"}, {"title": "CAR T-cell therapy for lymphoma", "authors": "Neelapu, S.S., Locke, F.L., Bartlett, N.L., Lekakis, L.J., Miklos, D.B., Jacobson, C.A., Braunschweig, I., Oluwole, O.O., Siddiqi, T., Lin, Y.", "journal": "Annual Review of Medicine", "year": "2018", "volumes": "69", "first page": "117", "last page": "130", "DOI": "10.1146/annurev-med-060116-022033"}, {"title": "Overcoming antigen escape with bispecific T-cell engagers in acute lymphoblastic leukemia", "authors": "Topp, M.S., GÃ¶kbuget, N., Stein, A.S., Zugmaier, G., O'Brien, S., Bargou, R.C., Dombret, H., Fielding, A.K., Heffner, L.T., Larson, R.A.", "journal": "Leukemia", "year": "2015", "volumes": "29", "first page": "239", "last page": "247", "DOI": "10.1038/leu.2014.186"}, {"title": "Chimeric antigen receptor T cells for sustained remissions in leukemia", "authors": "Maude, S.L., Frey, N., Shaw, P.A., Aplenc, R., Barrett, D.M., Bunin, N.J., Chew, A., Gonzalez, V.E., Zheng, Z., Lacey, S.F.", "journal": "New England Journal of Medicine", "year": "2014", "volumes": "371", "first page": "1507", "last page": "1517", "DOI": "10.1056/NEJMoa1407222"}, {"title": "CAR T cells: Engineering immune cells to treat cancer", "authors": "Sadelain, M., Brentjens, R., Riviere, I.", "journal": "Science", "year": "2013", "volumes": "342", "first page": "124", "last page": "126", "DOI": "10.1126/science.1242983"}]}